Nicergoline (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nicergoline" in English language version.

refsWebsite

Global rank English rank

7nih.gov

4^th place

5doi.org

2^nd place

4web.archive.org

1^st place

3semanticscholar.org

11^th place

8^th place

2europa.eu

68^th place

117^th place

2books.google.com

3^rd place

1businesswire.com

615^th place

407^th place

1viatris.com

low place

books.google.com

J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 864–. ISBN 978-1-4757-2085-3.
Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 727–. ISBN 978-3-88763-075-1. Archived from the original on 15 April 2021. Retrieved 15 April 2021.

businesswire.com

"Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan". Pfizer. 16 November 2020. Retrieved 17 June 2024 – via Business Wire.

doi.org

Zajdel P, Bednarski M, Sapa J, Nowak G (April 2015). "Ergotamine and nicergoline - facts and myths". Pharmacological Reports. 67 (2): 360–363. doi:10.1016/j.pharep.2014.10.010. PMID 25712664. S2CID 22768662.
Fioravanti M, Flicker L (2001). "Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment". The Cochrane Database of Systematic Reviews. 2001 (4): CD003159. doi:10.1002/14651858.CD003159. PMC 7025776. PMID 11687175.
Alvarez-Guerra M, Bertholom N, Garay RP (1999). "Selective blockade by nicergoline of vascular responses elicited by stimulation of alpha 1A-adrenoceptor subtype in the rat". Fundamental & Clinical Pharmacology. 13 (1): 50–58. doi:10.1111/j.1472-8206.1999.tb00320.x. PMID 10027088. S2CID 43871763.
Nishio T, Sunohara N, Furukawa S, Akiguchi I, Kudo Y (March 1998). "Repeated injections of nicergoline increase the nerve growth factor level in the aged rat brain". Japanese Journal of Pharmacology. 76 (3): 321–323. doi:10.1254/jjp.76.321. PMID 9593228.
Mizuno T, Kuno R, Nitta A, Nabeshima T, Zhang G, Kawanokuchi J, et al. (December 2005). "Protective effects of nicergoline against neuronal cell death induced by activated microglia and astrocytes". Brain Research. 1066 (1–2): 78–85. doi:10.1016/j.brainres.2005.10.050. PMID 16325157. S2CID 34963522.{{cite journal}}: CS1 maint: overridden setting (link)

europa.eu

ema.europa.eu

"List of nationally authorised medicinal products" (PDF). Archived (PDF) from the original on 11 July 2024. Retrieved 11 July 2024.
European Medicines Agency (28 June 2013), "New restrictions on use of medicines containing ergot derivatives", Press Release, archived from the original on 10 September 2018, retrieved 18 December 2013

nih.gov

pubmed.ncbi.nlm.nih.gov

Zajdel P, Bednarski M, Sapa J, Nowak G (April 2015). "Ergotamine and nicergoline - facts and myths". Pharmacological Reports. 67 (2): 360–363. doi:10.1016/j.pharep.2014.10.010. PMID 25712664. S2CID 22768662.
Fioravanti M, Flicker L (2001). "Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment". The Cochrane Database of Systematic Reviews. 2001 (4): CD003159. doi:10.1002/14651858.CD003159. PMC 7025776. PMID 11687175.
Alvarez-Guerra M, Bertholom N, Garay RP (1999). "Selective blockade by nicergoline of vascular responses elicited by stimulation of alpha 1A-adrenoceptor subtype in the rat". Fundamental & Clinical Pharmacology. 13 (1): 50–58. doi:10.1111/j.1472-8206.1999.tb00320.x. PMID 10027088. S2CID 43871763.
Moretti A, Carfagna N, Caccia C, Carpentieri M (1988). "Effect of ergolines on neurotransmitter systems in the rat brain". Archives Internationales de Pharmacodynamie et de Therapie. 294: 33–45. PMID 2906797.
Nishio T, Sunohara N, Furukawa S, Akiguchi I, Kudo Y (March 1998). "Repeated injections of nicergoline increase the nerve growth factor level in the aged rat brain". Japanese Journal of Pharmacology. 76 (3): 321–323. doi:10.1254/jjp.76.321. PMID 9593228.
Mizuno T, Kuno R, Nitta A, Nabeshima T, Zhang G, Kawanokuchi J, et al. (December 2005). "Protective effects of nicergoline against neuronal cell death induced by activated microglia and astrocytes". Brain Research. 1066 (1–2): 78–85. doi:10.1016/j.brainres.2005.10.050. PMID 16325157. S2CID 34963522.{{cite journal}}: CS1 maint: overridden setting (link)

ncbi.nlm.nih.gov

Fioravanti M, Flicker L (2001). "Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment". The Cochrane Database of Systematic Reviews. 2001 (4): CD003159. doi:10.1002/14651858.CD003159. PMC 7025776. PMID 11687175.

semanticscholar.org

api.semanticscholar.org

Zajdel P, Bednarski M, Sapa J, Nowak G (April 2015). "Ergotamine and nicergoline - facts and myths". Pharmacological Reports. 67 (2): 360–363. doi:10.1016/j.pharep.2014.10.010. PMID 25712664. S2CID 22768662.
Alvarez-Guerra M, Bertholom N, Garay RP (1999). "Selective blockade by nicergoline of vascular responses elicited by stimulation of alpha 1A-adrenoceptor subtype in the rat". Fundamental & Clinical Pharmacology. 13 (1): 50–58. doi:10.1111/j.1472-8206.1999.tb00320.x. PMID 10027088. S2CID 43871763.
Mizuno T, Kuno R, Nitta A, Nabeshima T, Zhang G, Kawanokuchi J, et al. (December 2005). "Protective effects of nicergoline against neuronal cell death induced by activated microglia and astrocytes". Brain Research. 1066 (1–2): 78–85. doi:10.1016/j.brainres.2005.10.050. PMID 16325157. S2CID 34963522.{{cite journal}}: CS1 maint: overridden setting (link)

viatris.com

"Brands". Viatris. 16 November 2020. Archived from the original on 17 June 2024. Retrieved 17 June 2024.

web.archive.org

"List of nationally authorised medicinal products" (PDF). Archived (PDF) from the original on 11 July 2024. Retrieved 11 July 2024.
European Medicines Agency (28 June 2013), "New restrictions on use of medicines containing ergot derivatives", Press Release, archived from the original on 10 September 2018, retrieved 18 December 2013
Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 727–. ISBN 978-3-88763-075-1. Archived from the original on 15 April 2021. Retrieved 15 April 2021.
"Brands". Viatris. 16 November 2020. Archived from the original on 17 June 2024. Retrieved 17 June 2024.